Merck breaks ground on new $1 billion Biologics Center of Excellence in Delaware, US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Bloom has pioneered a technology to transform plant waste into valuable chemical products
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Subscribe To Our Newsletter & Stay Updated